Condition
Maturity Onset Diabetes of the Young
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07492004Recruiting
China Monogenic Diabetes Registry
NCT07029009Phase 2RecruitingPrimary
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
NCT05687474Completed
Baby Detect : Genomic Newborn Screening
NCT02082132Unknown
MODY in Young-onset Diabetes in Different Ethnicities
Showing all 4 trials